Piermont Capital Management Inc. - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 173 filers reported holding ANI PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.

Quarter-by-quarter ownership
Piermont Capital Management Inc. ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$298,000
-4.2%
4,460
-16.5%
0.09%
-12.5%
Q1 2018$311,000
-21.9%
5,340
-13.5%
0.10%
-20.6%
Q4 2017$398,000
+16.0%
6,170
-5.5%
0.13%
+14.9%
Q3 2017$343,000
-43.8%
6,530
-49.9%
0.11%
-34.5%
Q2 2017$610,000
-19.4%
13,040
-14.7%
0.17%
-3.3%
Q1 2017$757,000
+72.4%
15,290
+111.2%
0.18%
+80.0%
Q4 2016$439,000
-10.4%
7,240
-1.9%
0.10%
-13.8%
Q3 2016$490,0007,3800.12%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
FIRST WILSHIRE SECURITIES MANAGEMENT INC 367,754$10,911,0004.08%
AIGH Capital Management LLC 244,500$7,254,0001.91%
Parkman Healthcare Partners LLC 108,559$3,221,0001.19%
Worth Venture Partners, LLC 60,831$1,927,0001.13%
Global Alpha Capital Management Ltd. 323,731$9,605,0001.04%
Mesirow Financial Investment Management, Inc. 6,892$204,0000.99%
MARATHON CAPITAL MANAGEMENT 74,460$2,209,0000.71%
EMERALD ADVISERS, LLC 455,880$13,526,0000.70%
EMERALD MUTUAL FUND ADVISERS TRUST 356,865$10,588,0000.61%
Jackson Creek Investment Advisors LLC 32,698$1,120,0000.45%
View complete list of ANI PHARMACEUTICALS INC shareholders